As researchers and healthcare professionals seek new ways to tackle chronic diseases, targeted approaches like this one could ...

A new study published in the Journal of Physiology reveals that ketone production in the liver plays a critical role in ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Learn 8 tips to enhance your livers natural detoxification abilities, protect against damage, and support metabolic health ...

To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

Non-invasive biomarkers and scoring systems show strong capability in differentiating chronic liver disease from cirrhosis, ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...